https://www.reuters.com/markets/deals/gilead-buys-out-rights-cancer-therapy-jounce-67-mln-2022-12-28/
0
0
12/28/22 at 2:34am
Organization
Reuters
Authors
Gilead Sciences <a href="https://www.reuters.com/companies/GILD.O" target="_blank">(GILD.O)</a> will buy all the remaining rights for an experimental cancer therapy, GS-1811, from Jounce Therapeutics <a href="https://www.reuters.com/companies/JNCE.O" target="…
Create an account
or login to join the discussion